Chickenpox Vaccine Market Overview 2024-2033: Share, Size, Insights, Forecast

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Chickenpox Vaccine Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $4.64 billion In 2028 At A CAGR Of 6.5% :

The chickenpox vaccine market size has grown strongly in recent years. It will grow from $3.38 billion in 2023 to $3.61 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to vaccine development, regulatory approvals, disease incidence, vaccination policies, public health initiatives.

The chickenpox vaccine market size is expected to see strong growth in the next few years. It will grow to $4.64 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to public perception and trust, pandemic preparedness, research and development, emerging market demand, healthcare infrastructure development. Major trends in the forecast period include vaccine education campaigns, adverse event monitoring, vaccine pricing strategies, advanced innovation, use of AI.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8581&type=smp

Chickenpox Vaccine Market Major Segments
The chickenpox vaccine market covered in this report is segmented -

1) By Vaccine: Monovalent varicella vaccine, Combination varicella vaccine
2) By Application: Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination
3) By End-Users: Hospitals, Clinics, Other End-Users

Key Driver - Surge In Chickenpox Cases Driving Growth In Vaccine Market

The rising prevalence of chickenpox disease is expected to propel the growth of the chickenpox vaccine market going forward. Chickenpox disease refers to a severe infectious disease caused by the varicella-zoster virus (VZV) that causes a fluid-filled rash with an itchy rash. Increased cases of chickenpox necessitate more varicella vaccine immunization, thus, increasing demand for chickenpox vaccines. For instance, in April 2021, according to a report published by the Centers for Disease Control and Prevention (CDC), a US-based international public health agency, in the USA, around 4 million people have chickenpox annually, and over 10, 500 of them end up in hospitals, and between 100 and 150 of them pass away. Therefore, the rising prevalence of chickenpox disease is driving the growth of the chickenpox vaccine market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=8581&type=smp

Prominent Trend - Innovative Drug Developments Transform Chickenpox Vaccine Landscape

Novel drug developments are the key trend gaining popularity in the chickenpox vaccine market. Major companies operating in the market are developing novel drugs with improved efficacy, innovative derivatives, and others to sustain their position in the market. For instance, in November 2022, Sinovac Biotech Ltd., a China-based company focused on research, development, and manufacturing of vaccines, stated that the World Health Organization (WHO) granted it prequalification for its live attenuated chickenpox (varicella) vaccine, which is the world's first varicella vaccine to receive prequalification. The Oka strain is the source of the varicella vaccine, which is produced in the exclusive Human Diploid Cell (SV-1 strain) of SINOVAC. This cell is created by cultivating and harvesting the virus, adding stabilizers, and freeze-drying it. A phase III efficacy trial found that the seroconversion rate of the vaccine-embedded children group, aged 1 to 12 years old, was 97.1%; the vaccine's efficacy against varicella and against breakthrough varicella was 87.1% and 89.2%, respectively. The vaccine offers 100 percent defense against mild and serious conditions.

Chickenpox Vaccine Market Players
Major companies operating in the chickenpox vaccine market report are Pfizer Inc., Merck & Co Inc., Novartis AG, Sanofi Pasteur, AstraZeneca plc., GlaxoSmithKline plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Zydus Lifesciences Limited, Green Cross Corporation, Sinovac Biotech Ltd., GC Biopharma Corp., Emergent BioSolutions Inc., Bharat Biotech, Novo Medi Sciences Pvt. Ltd., Hualan Biological Engineering Inc., Chongqing Zhifei Biological Products Co. Ltd., Walvax Biotechnology Co. Ltd., Bavarian Nordic A/S, Valneva SE, Serum Institute of India, Shenzhen Kangtai Biological Products Co. Ltd., SK Bioscience Co.Ltd., Biological E. Limited, PanGen Biotech Inc., Bio-Med, Parc-vaccinogène en Instituut Pasteur, Lucky Chemical Industrial Corporation, Biocad India Private Limited, Virchow Biotech Pvt. Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the chickenpox vaccine market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chickenpox vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chickenpox Vaccine Market Report Structure
3. Chickenpox Vaccine Market Trends And Strategies
4. Chickenpox Vaccine Market - Macro Economic Scenario
5. Chickenpox Vaccine Market Size And Growth
…..
27. Chickenpox Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.